1216704-11-8
1216704-11-8
Chemical Structure
(±)-Naproxen-13C,d3-1
Synonym(s): (Rac)-Naproxen-13C,d3-1
- CAS No.: 1216704-11-8
- Formula:C1313CH11D3O3
- Molecular Weight:234.27
InChIKey: CMWTZPSULFXXJA-KQORAOOSSA-N
SMILES: COC1=CC2=C(C=C1)C=C(C(C(O)=O)[13C]([2H])([2H])[2H])C=C2
Biological Activity: (±)-Naproxen-13C,d3-1 ((Rac)-Naproxen-13C,d3-1) is 13C and deuterium labeled (±)-Naproxen[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(±)-Naproxen-13C,d3-1 | (±)-Naproxen-13C,d3-1 ((Rac)-Naproxen-13C,d3-1) is 13C and deuterium labeled (±)-Naproxen. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen (Standard) | ≥98% | (±)-Naproxen (Standard) is the analytical standard of (±)-Naproxen. This product is intended for research and analytical applications. (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-d3 | 99.77% | (±)-Naproxen-d3 is the deuterium labeled (±)-Naproxen. (±)-Naproxen is a non-steroidal anti-inflammatory drug (NSAID). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-13C,d3 | (±)-Naproxen-13C,d3 is the deuterium and 13C labeled (±)-Naproxen. (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen-d3-1 | (±)-Naproxen-d3-1 is the deuterium labeled (±)-Naproxen. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Naproxen | 99.79% | (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
